Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
Release from the company regarding the company's response to the auditor's reservations concerning the standalone and consolidated financial statements for the financial period ended on 30/06/2026.
Minapharm Pharmaceuticals (MIPH.CA) - Company's Response to the Auditor's Report
Filed with EGX · · 4 pages · Arabic
Release
Minapharm Pharmaceuticals on 6ix
Story so far
Earlier from Minapharm Pharmaceuticals
- Minapharm Pharmaceuticals (MIPH.CA) Reports 6 Months Consolidated Results
- Minapharm Pharmaceuticals FY Standalone Net Profit EGP 57.5 Million
- Minapharm Pharmaceuticals Q3 Consol Profit EGP 16.8 Million
Follow Minapharm Pharmaceuticals into a list and get an email when it puts out news.
Follow Minapharm Pharmaceuticals